Litcius/Paper detail

Gut Microbiota and Their Metabolites: The Hidden Driver of Diabetic Nephropathy? Unveiling Gut Microbe's Role in <scp>DN</scp>

Jinzhou Liu, Min Guo, Xiaobin Yuan, Xiao Fan, Jin Wang, Xiangying Jiao

2025Journal of Diabetes9 citationsDOIOpen Access PDF

Abstract

BACKGROUND: Diabetic nephropathy (DN) is a severe microvascular complication of diabetes with a complex pathogenesis. METHODS: Recent studies were reviewed to explore the role of gut microbiota and its metabolites in DN development. RESULTS: Dysbiosis of gut bacteria contributes to pathological changes such as glomerular sclerosis and renal tubule injury. Microbial metabolites are involved in DN through immune and inflammatory pathways. CONCLUSIONS: Understanding the relationship between gut microbiota, its metabolites, and DN may offer potential implications for DN diagnosis, prevention, and treatment. Translating this knowledge into clinical practice presents challenges and opportunities.

Topics & Concepts

Gut floraMedicineDiabetic nephropathyDiabetes mellitusDysbiosisPathogenesisNephropathyPathologicalImmune systemBioinformaticsImmunologyInternal medicineEndocrinologyBiologyGut microbiota and healthDiabetes Management and EducationClostridium difficile and Clostridium perfringens research